Related Experiment Video
Updated: Nov 3, 2025

Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase
Published on: October 15, 2018
DNMT3A Mutation-Induced CDK1 Overexpression Promotes Leukemogenesis by Modulating the Interaction between EZH2 and
Ying Yang1, Yujun Dai1, Xuejiao Yang1
1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Cyclin-dependent kinase 1 (CDK1) overexpression promotes acute myeloid leukemia (AML) with DNMT3A mutations. Inhibiting CDK1 may offer a new therapeutic strategy for this aggressive cancer.
Area of Science:
- Molecular Biology
- Cancer Biology
- Hematology
Background:
- DNMT3A mutations are common in acute myeloid leukemia (AML) and associated with poor prognosis.
- Previous research linked the DNMT3A R882H mutation to CDK1 upregulation and AML induction in mice.
Purpose of the Study:
- To elucidate the mechanism of CDK1 in DNMT3A mutation-related AML pathogenesis.
- To investigate CDK1 as a potential therapeutic target for AML.
Main Methods:
- Fluorescence resonance energy transfer (FRET) and immunoprecipitation assays.
- CDK1 knockdown in OCI-AML3 cells (harboring DNMT3A mutation).
- Treatment with CDK1 inhibitors (CGP74514A and flavopiridol) and combination therapy.
Main Results:
- Increased CDK1 competes with EZH2 for binding to DNMT3A, disrupting EZH2-DNMT3A interaction.
- CDK1 knockdown inhibited proliferation and induced apoptosis in OCI-AML3 cells.
- CDK1 inhibitors caused G2/M phase arrest, induced apoptosis, and increased CD163-positive cells. Combination therapy showed synergistic effects.
Conclusions:
- CDK1 overexpression is a pathogenic factor in DNMT3A mutation-related AML.
- Targeting CDK1 presents a promising therapeutic avenue for this AML subtype.
More Related Videos
06:07Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
08:34Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
Published on: April 13, 2015
Related Concept Videos
Abnormal Proliferation
Inhibition of Cdk Activity
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Mitogens and the Cell Cycle
DNA Damage can Stall the Cell Cycle
Positive Regulator Molecules